You are here



Barcelona, 28 September 2023. –BIOSPAIN 2023, the international reference event for the biotechnology sector, has concluded its eleventh edition today in Barcelona with record-breaking participation figures: over the course of three days, more than 2,100 people from 975 entities and from 30 countries participated, a figure that is above the initial forecasts.

The Barcelona edition becomes the most crowded in history, both in number of attendees - 30% more than the last pre-pandemic edition held in 2018 -, entities (975), exhibitors (220),...

The startups from the BioRegion have beaten investment records in little over six months

By July 2022, the health startups in Catalonia had already raised 296 million euros, exceeding the total figure for 2021. However, the international situation and generalised stringency in investment call for caution in year-end forecasts.


Hybrid: London and online

alumnes de la Summer School on Medicines

Over two weeks, the course will cover the whole drug-development value chain

Dr. Khalid Islam

Dr. Khalid Islam has extensive experience in the pharmaceutical and biotechnology industry and the company believes he can lead them to great successes

L'equip d'Aelix Therapeutics

Biotechnology firm Aelix Therapeutics has received funding from Ysios Capital, Caixa Capital Risc and Johnson & Johnson Innovation

L'IRB Barcelona crea un model ‘excepcional’ de simulació de l’ADN

Researchers have also presented the first platform for atomic-level simulation of nucleic acids

Campanya de crowdequity Mind the Byte

The company raised €234,310 from 115 investors through the Crowdcube platform, which is shaping up as the funding alternative in biotechnology

Martinell Minoryx

The company, which specializes in drug development for rare or minority diseases without treatment, has received €19.4